The use of sphingolipids in the treatment and prevention of type 2 diabetes mellitus, insulin resistance and Metabolic Syndrome

Details for Australian Patent Application No. 2005220692 (hide)

Owner Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO

Inventors Nieuwenhuizen, Willem Ferdinand; Havekes, Aloysius Maria; Emeis, Josephus Jan

Agent Griffith Hack

Pub. Number AU-A-2005220692

PCT Pub. Number WO2005/087023

Priority 04077088.5 19.07.04 EP; 04075848.4 16.03.04 EP

Filing date 15 March 2005

Wipo publication date 22 September 2005

International Classifications

A61K 31/688 (2006.01)

A23L 1/30 (2006.01) Foods or foodstuffs - containing additives

A61K 31/133 (2006.01) - having hydroxy groups, e.g. sphingosine

A61K 31/164 (2006.01) - of a carboxylic acid with an aminoalcohol, e.g. ceramides

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/087023 Priority application(s): WO2005/087023

13 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005220694-A method of improving the efficiency of fat separation in the separation of a liquid food product

2005220688-Ankle support to be attached to footwear and footwear equipped with it